HealthZealand Pharma Reports No Dose-Limiting Safety Findings in ZP9830’s Phase 1 MAD StudyBy Naomi CalderOct 19, 2026, 7:02 AM UTC
BusinessBeyond Celiac hiring Chief Scientific Officer Marie Robert, MDBy Nasdaq OMXFeb 6, 2018, 7:26 PM UTC
BusinessBeyond Celiac Announces Addition of New Board Members, New Board ChairBy Nasdaq OMXJan 25, 2018, 5:04 PM UTC
BusinessFDA offers guidance on gluten-labeling for medicationsBy Nasdaq OMXDec 13, 2017, 10:21 PM UTC
BusinessBeyond Celiac to host Bold Beyond Celiac Disease Research SymposiumBy Nasdaq OMXOct 4, 2017, 5:55 PM UTC
BusinessBeyond Celiac Announces Innovative Collaborative Research Effort: Go Beyond Celiac digital communityBy Nasdaq OMXSep 6, 2017, 3:59 PM UTC
BusinessPatent for Reducing Inflammatory Response Granted to Galectin TherapeuticsBy Nasdaq OMXJun 21, 2017, 12:30 PM UTC
BusinessPROTAGEN Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune DiseasesBy Nasdaq OMXDec 13, 2016, 3:52 PM UTC
